Chronic total occlusions, a true challenge

Original title: Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention. A Report From the NCDR (National Cardiovascular Data Registry). Reference: Emanuel S. Brilakis, et al. JACC Cardiovascular Intervention 2015;8:245-53

Chronic total occlusions (CTO) are present in 20% to 50% of pathological coronary angiograms but, even though this percentage has increased in the past years, PCI is performed in around 4% of this kind of lesions.

This study included 594,510 stable patients; 22,365 of them (3.8%) received CTO PCI. Patients presenting CTO were younger, more frequently men, often with prior infarction, prior PCI and ventricular failure.

Procedural success was lower for CTO (59% vs. 96%; p<0.001), with marked variability in centers and operators. Procedural success was associated to the annual volume of CTO PCIs of operators, 10 being 53%, 62% and 75% (p<0.001). The group requiring vessel revascularization required greater contrast volume and longer fluoroscopy time.

Procedural success also increased with operator experience, 55.5% in 2009 to 61.9% in 2013 (p<0.01). Multivariable analysis associated lower procedural success to age, smoking, previous myocardial infarction, previous CABG, previous peripheral heart disease, right coronary artery CTO target vessel and less operator experience.

Combined events resulted higher in CTO PCIs than in conventional PCIs (1.6% vs. 0.8% p<0.001). More operator experience was associated to a lower events risk.

Conclusion

CTO PCI is not frequent in USA in stable patients and is associated to a lower procedural success and a higher complications rate, compared to outcomes in patients that do not present CTO. Success is associated with patient characteristics and operator experience.

Editorial Comment

When performing CTI success will depend on operator and center. Different studies have shown the benefits of revascularization, especially when it comes to the anterior descending artery.

Courtesy of Dr. Carlos Fava
Interventional Cardiologist
Favaloro Foundation– Argentina

Carlos Fava

Previous article
Next article

More articles by this author

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...